VRTX

Vertex Pharmaceuticals Inc. Reports Rise In Q4 Bottom Line

(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX) reported earnings for its fourth quarter that Increases, from last year

The company's earnings came in at $1.191 billion, or $4.65 per share. This compares with $913.0 million, or $3.50 per share, last year.

Excluding items, Vertex Pharmaceuticals Inc. reported adjusted earnings of $1.287 billion or $5.03 per share for the period.

The company's revenue for the period rose 9.5% to $3.190 billion from $2.912 billion last year.

Vertex Pharmaceuticals Inc. earnings at a glance (GAAP) :

-Earnings: $1.191 Bln. vs. $913.0 Mln. last year. -EPS: $4.65 vs. $3.50 last year. -Revenue: $3.190 Bln vs. $2.912 Bln last year.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.